Pfizer Inc. reported earnings results for the first quarter ended March 30, 2025. For the first quarter, the company reported revenue was USD 13,715 mi...
Johnson & Johnson Competitors or Alternatives
Johnson & Johnson's top competitors include Pfizer, Merck and Novartis.
Johnson & Johnson VS Pfizer
With an approval rating of 68 out of 100, the CEO at Pfizer, Albert Bourla has a higher approval rating than the CEO at Johnson & Johnson. Joaquin Duato, Johnson & Johnson CEO has an approval rating of 61 out of 100. Pfizer has a higher annual revenue totaling an estimated $93B compared to the total annual revenue of Johnson & Johnson which is estimated at $96.3B. Johnson & Johnson outnumbers Pfizer in terms of employee count. Pfizer employs 83,000 versus the 152,700 people Johnson & Johnson employs. Pfizer and Johnson & Johnson both have 44 subsidiaries. The latest acquisition for Pfizer took place in April 2023. Lucira Health, Inc. was acquired by Pfizer for $36.4M. Nov 2022 is when the last acquisition by Johnson & Johnson occurred. Abiomed, Inc was acquired by Johnson & Johnson for $16.6B. April 2023 saw Meenakshi Nevatia join Pfizer as the CEO and Managing Director for Pfizer India.
Johnson & Johnson VS Novartis
Vasant Narasimhan is the CEO of Novartis. Narasimhan’s approval rating is 67 out of 100. This is higher than the rating of 61 out of 100 that Joaquin Duato of Johnson & Johnson received. $96.3B is the total annual revenue of Johnson & Johnson. This number is significantly greater than the $50.5B annual revenue that Novartis earns. With 44 subsidiaries, Johnson & Johnson outnumbers the number of acquisitions Novartis has made. Novartis has 25 subsidiaries with its latest acquisition of Kedalion Therapeutics, Inc. occurring Jun 2022. In early May 2023, Novartis released its Q1 2023 Impact and Sustainability Update. It was reported that in early May 2023, Novartis was sued in U.S. court by Amgen Inc. Shahram Ebadollahi, departed from their role as Chief Data And AI Officer at Novartis in Feb 2023 while Simone Fantaccini joined Novartis as Head of Medical Addairs and Chief Scientific Officer in Nov 2022.
Johnson & Johnson VS Merck
Robert M. Davis is the CEO at Merck. Davis has an approval rating of 83 out of 100. This approval rating is significantly higher than Johnson & Johnson CEO Joaquin Duato who has an approval rating of 61 out of 100. With 69,000 employees, Merck has a smaller number of individuals employed than Johnson & Johnson which has 152,700 employees. The total annual revenue of Johnson & Johnson is $96.3B while Merck generated a lower total annual revenue at $57.9B. Merck has 28 subsidiaries with its latest acquisition of Prometheus Biosciences, Inc. occurring Apr 2023. Comparatively, Johnson & Johnson has 44 subsidiaries with their latest acquisition of Abiomed, Inc. occurring in Nov 2022. In Seo 2022, George Addona joined Merck as VP of Quantitative Biosciences. Nov 2022 saw Bhargavi Kakunuri join Merck as Head of Human Resources.
Looking for similar companies to Johnson & Johnson?
Similar Companies
Companies in New Jersey with employees in 100K-9.9M range
See 10 companies
Pharmaceuticals companies in New BrunswickSee 12 companies
Pharmaceuticals & Biotechnology companies with employees in 100K-9.9M rangeSee 11 companies
Pharmaceuticals & Biotechnology companies with revenue in $50-100B rangeSee 12 companies
Pharmaceuticals companies with revenue in $50-100B rangeSee 12 companies
Companies in New York Metropolitan Area with revenue in $50-100B rangeSee 21 companies
Pharmaceuticals & Biotechnology companies in New BrunswickSee 26 companies
Companies in New York Metropolitan Area with employees in 100K-9.9M rangeSee 28 companies
Companies in USA with revenue in $50-100B rangeSee 89 companies
Trending News for Johnson & Johnson and Johnson & Johnson's Competitors
Early findings from Johnson & Johnson's Phase IIb SunRISe-1 trial show the promise of TAR-200 in patients with Bacillus Calmette-Guérin-unresponsive, h...
Novartis AG NVS reported first-quarter 2025 adjusted earnings per share of $2.28, beating the street view of $2.10 . Quarterly sales of $13.23 billion ...
Frequently Asked Questions about Johnson & Johnson
Who are Johnson & Johnson's top competitors?
Johnson & Johnson's top 3 competitors are Pfizer, Merck, Novartis.Who is similar to Johnson & Johnson?
Pfizer is the most similar to Johnson & Johnson. Merck and Novartis are also similar to Johnson & Johnson.
Are Johnson & Johnson and Pfizer competitors?
Yes, Pfizer is one of Johnson & Johnson’s top competitors.